News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
498,079 Results
Type
Article (34331)
Company Profile (65)
Press Release (463674)
Multimedia
Podcasts (106)
Webinars (12)
Section
Business (133202)
Career Advice (2537)
Deals (26733)
Drug Delivery (111)
Drug Development (63600)
Employer Resources (145)
FDA (11730)
Job Trends (10875)
News (238139)
Policy (23195)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1936)
Academic (1)
Accelerated approval (36)
Adcomms (21)
Allergies (137)
Alliances (33810)
ALS (186)
Alzheimer's disease (1566)
Antibody-drug conjugate (ADC) (333)
Approvals (11996)
Artificial intelligence (493)
Autoimmune disease (193)
Automation (37)
Bankruptcy (239)
Best Places to Work (8690)
BIOSECURE Act (19)
Biosimilars (157)
Biotechnology (51)
Bladder cancer (162)
Brain cancer (53)
Breast cancer (615)
Cancer (4648)
Cardiovascular disease (391)
Career advice (2119)
Career pathing (43)
CAR-T (249)
CDC (57)
Cell therapy (678)
Cervical cancer (38)
Clinical research (55587)
Collaboration (1594)
Company closure (3)
Compensation (468)
Complete response letters (70)
COVID-19 (2348)
CRISPR (74)
C-suite (643)
Cystic fibrosis (126)
Data (6221)
Decentralized trials (3)
Denatured (18)
Depression (153)
Dermatology (48)
Diabetes (466)
Diagnostics (5487)
Digital health (38)
Diversity (7)
Diversity, equity & inclusion (31)
Drug discovery (238)
Drug pricing (169)
Drug shortages (27)
Duchenne muscular dystrophy (255)
Earnings (64343)
Editorial (63)
Employer branding (19)
Employer resources (127)
Events (77867)
Executive appointments (669)
FDA (14674)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1167)
Gene editing (179)
Generative AI (44)
Gene therapy (576)
GLP-1 (922)
Government (3809)
Grass and pollen (4)
Guidances (390)
Healthcare (13112)
HIV (62)
Huntington's disease (47)
IgA nephropathy (91)
Immunology and inflammation (268)
Immuno-oncology (85)
Indications (141)
Infectious disease (2621)
Inflammatory bowel disease (175)
Inflation Reduction Act (10)
Influenza (108)
Intellectual property (249)
Interviews (486)
IPO (13711)
IRA (40)
Job creations (2469)
Job search strategy (1747)
JPM (62)
Kidney cancer (18)
Labor market (79)
Layoffs (421)
Leadership (43)
Legal (4652)
Liver cancer (90)
Longevity (19)
Lung cancer (631)
Lymphoma (367)
Machine learning (37)
Management (54)
Manufacturing (752)
MASH (162)
Medical device (9944)
Medtech (9991)
Mergers & acquisitions (14069)
Metabolic disorders (1271)
mRNA (175)
Multiple sclerosis (159)
NASH (14)
Neurodegenerative disease (373)
Neuropsychiatric disorders (95)
Neuroscience (2827)
Neurotech (1)
NextGen: Class of 2026 (4141)
Non-profit (2710)
Now hiring (44)
Obesity (606)
Opinion (311)
Ovarian cancer (164)
Pain (190)
Pancreatic cancer (224)
Parkinson's disease (295)
Partnered (26)
Patents (491)
Patient recruitment (483)
Peanut (48)
People (33908)
Pharmaceutical (15)
Pharmacy benefit managers (23)
Phase 1 (17091)
Phase 2 (24780)
Phase 3 (19179)
Pipeline (6415)
Policy (268)
Postmarket research (1646)
Preclinical (6464)
Press Release (56)
Prostate cancer (240)
Psychedelics (41)
Radiopharmaceuticals (242)
Rare diseases (908)
Real estate (3693)
Recruiting (61)
Regulatory (18894)
Reports (41)
Research institute (1776)
Resumes & cover letters (430)
Rett syndrome (27)
RNA editing (14)
RSV (72)
Schizophrenia (151)
Series A (173)
Series B (127)
Service/supplier (4)
Sickle cell disease (92)
Special edition (24)
Spinal muscular atrophy (155)
Sponsored (37)
Startups (2315)
State (1)
Stomach cancer (18)
Supply chain (95)
Tariffs (74)
The Weekly (86)
Vaccines (965)
Venture capital (90)
Weight loss (416)
Women's health (79)
Worklife (22)
Date
Last 7 days (518)
Last 30 days (2056)
Last 365 days (24627)
2026 (6487)
2025 (24897)
2024 (28469)
2023 (32152)
2022 (40768)
2021 (42822)
2020 (40816)
2019 (32111)
2018 (24261)
2017 (24739)
2016 (22531)
2015 (26581)
2014 (19035)
2013 (22338)
2012 (15802)
2011 (16368)
2010 (14474)
Location
Africa (686)
Alabama (83)
Alaska (5)
Arizona (176)
Arkansas (7)
Asia (30199)
Australia (5065)
California (9741)
Canada (2941)
China (1027)
Colorado (409)
Connecticut (434)
Delaware (297)
Europe (68080)
Florida (1503)
Georgia (311)
Hawaii (2)
Idaho (30)
Illinois (689)
India (58)
Indiana (468)
Iowa (15)
Japan (422)
Kansas (96)
Kentucky (21)
Louisiana (28)
Maine (77)
Maryland (1210)
Massachusetts (6766)
Michigan (262)
Minnesota (491)
Mississippi (4)
Missouri (111)
Montana (29)
Nebraska (16)
Nevada (108)
New Hampshire (62)
New Jersey (2807)
New Mexico (26)
New York (2680)
North Carolina (1130)
North Dakota (3)
Northern California (4828)
Ohio (267)
Oklahoma (15)
Oregon (36)
Pennsylvania (1959)
Puerto Rico (23)
Rhode Island (30)
South America (893)
South Carolina (63)
Southern California (3864)
Tennessee (137)
Texas (1572)
United States (34379)
Utah (301)
Vermont (1)
Virginia (230)
Washington D.C. (63)
Washington State (797)
West Virginia (3)
Wisconsin (69)
Wyoming (2)
498,079 Results for "biom up".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
January 13, 2026
·
8 min read
Press Releases
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026
·
12 min read
Press Releases
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - February 19, 2026
February 19, 2026
·
2 min read
Press Releases
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
February 17, 2026
·
4 min read
Press Releases
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
March 11, 2026
·
5 min read
Press Releases
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
March 30, 2026
·
15 min read
Mergers & acquisitions
Lilly Wakes Up Sleep Market With $6.3B Centessa Buy To Challenge Takeda
In the buyout, Eli Lilly picks up Centessa Pharmaceuticals’ lead asset cleminorexton, which could go toe-to-toe with Takeda’s oveporexton, currently under FDA review with a decision expected in the third quarter.
March 31, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation
March 19, 2026
·
3 min read
Breast cancer
Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals
Aside from the $2 billion upfront payment, Novartis is also putting up to $1 billion on the line in milestones for Synnovation Therapeutics’ pan-mutant-selective PI3Kα blocker.
March 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients
March 23, 2026
·
7 min read
1 of 49,808
Next
